Eyepoint Pharmaceuticals Stock Forecast

Sell candidate since Jul 14, 2026 Loss -5.03%

The EyePoint Pharmaceuticals Inc. stock price fell by -5.85% on the last day (Thursday, 16th Jul 2026) from $13.85 to $13.04. During the last trading day the stock fluctuated 10.42% from a day low at $12.86 to a day high of $14.20. The price has fallen in 6 of the last 10 days and is down by -1.17% for this period. Volume has increased on the last day by 122 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $20.21 million.

The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect EyePoint Pharmaceuticals Inc. stock with a 90% probability to be traded between $11.95 and $15.03 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

EYPT Signals & Forecast

There are few to no technical positive signals at the moment. The EyePoint Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $14.07 and $13.36. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, July 09, 2026, and so far it has fallen -12.13%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for EyePoint Pharmaceuticals Inc. stock

EyePoint Pharmaceuticals Inc. finds support from accumulated volume at $12.88 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.34 between high and low, or 10.42%. For the last week, the stock has had daily average volatility of 6.62%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EYPT) For The Upcoming Trading Day Of Friday 17th

For the upcoming trading day on Friday, 17th we expect EyePoint Pharmaceuticals Inc. to open at $13.37, and during the day (based on 14 day Average True Range), to move between $12.55 and $13.53, which gives a possible trading interval of +/-$0.97 (+/-7.73%) up or down from last closing price. If EyePoint Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 7.73% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $12.88 (1.23%) than the resistance at $13.66 (4.75%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is EyePoint Pharmaceuticals Inc. stock A Buy?

EyePoint Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.829 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 17, 2026 - $13.37 ( 2.51%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk